J9059 — Injection, bendamustine hydrochloride (baxter), 1 mg
J9059 is a HCPCS Level II code for injection, bendamustine hydrochloride (baxter), 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2024 and is not valid on new claims.
This code has been terminated
CMS terminated J9059 on December 31, 2024. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J9059
- Long descriptor
- Injection, bendamustine hydrochloride (baxter), 1 mg
- Short descriptor
- Inj bendamustine, baxter 1mg
- Added
- July 1, 2023
- Terminated
- December 31, 2024
- BETOS
- O1D
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J9059
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J9059 is not quite right, the correct code is very often within a few positions of it.
- J9051Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
- J9052Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg
- J9053Injection, belantamab mafodotin-blmf, 0.1 mg
- J9054Injection, bortezomib (boruzu), 0.1 mg
- J9055Injection, cetuximab, 10 mg
- J9056Injection, bendamustine hydrochloride (vivimusta), 1 mg
- J9057Injection, copanlisib, 1 mg
- J9058Injection, bendamustine hydrochloride (apotex), 1 mgterminated
- J9060Injection, cisplatin, powder or solution, 10 mg
- J9061Injection, amivantamab-vmjw, 2 mg
- J9062Injection, amivantamab 5 mg and hyaluronidase-lpuj
- J9063Injection, mirvetuximab soravtansine-gynx, 1 mg
- J9064Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg
- J9065Injection, cladribine, per 1 mg
- J9070Cyclophosphamide, 100 mgterminated
- J9071Injection, cyclophosphamide (auromedics), 5 mg
Questions about J9059
What is HCPCS code J9059?
J9059 is a HCPCS Level II code for injection, bendamustine hydrochloride (baxter), 1 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J9059?
The CMS HCPCS file marks J9059 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J9059 still valid?
No. J9059 was terminated on December 31, 2024 and should not be used on new claims.